# US 2004/0081684 A1 · Topical delivery of antifungal agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0081684 A1
- Document ID: US20040081684A1
- Status: Published application
- Kind: A1
- Application number: 10/644,085
- Filed: 2003-08-20
- Published: 2004-04-29
- Earliest claimed: 1996-02-19
- Assignees: Monash University
- Inventors: Nora Yat Knork Chew; Barry Leonard Reed; Timothy Matthias Morgan; Barrie Charles Finnin
- Web page: https://patentgrep.com/patent/US20040081684A1

## CPC

- A61K 8/046: {Aerosols; Foams}
- A61K 8/37: Esters of carboxylic acids
- A61K 8/445: {aromatic, i.e. the carboxylic acid directly linked to the aromatic ring}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/12: Aerosols; Foams {(A61K9/0043, A61K9/0056, A61K9/006, A61K9/0073 take precedence; spray-films A61K9/7015)}
- A61K 9/122: {Foams; Dry foams (edible foams A61K9/0056)}
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61M 35/003: {Portable hand-held applicators having means for dispensing or spreading integral media (hand-held massage devices with liquid delivery A61H7/003)}
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention provides a topical drug delivery system which comprises: a therapeutically effective amount of an antifungal agent; at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester; and a volatile liquid. The invention also provides a method for administering at least one systemic acting antifungal agent to an animal which comprises applying an effective amount of the antifungal agent in the form of the drug delivery system of the present invention.

## Claims

### Claim 1

A topical drug delivery system which comprises:
a. a therapeutically effective amount of an antifungal agent;
b. at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen of formula (I):
2
wherein
R1 is hydrogen, lower alkyl, lower alkoxy, halide, hydroxy or NR3R4;
R2 is a C8 to C18 alkyl,
R3 and R4 are each independently hydrogen, lower alkyl or R3 and R4 together with the nitrogen atom to which they are attached form a 5- or 6-membered heterocyclic ring;
n is 0 or 1, and
q is 1 or 2,
wherein when n is 0 and R1 is NR3 R4, then NR3 R4 is para-substituted; and wherein said dermal penetration enhancer is present in an amount of from about 10 to about 10,000 wt % based on the weight of the antifungal agent; and
c. a volatile liquid.

### Claim 2 (depends on 1)

A topical drug delivery system according to claim 1, wherein the dermal penetration enhancer is octyl salicylate.

### Claim 3 (depends on 2)

A topical drug delivery system according to claim 2, wherein the antifungal agent is selected from the list consisting of amorolfine, isoconazole, clotrimazole, econazole, miconazole, nystatin, terbinafine, bifonazole, amphotericin, griseofulvin, ketoconazole, fluconazole and flucytosine, salicylic acid, fezatione, ticlatone, tolnaftate, triacetin, zinc pyrithione and sodium pyrithione.

### Claim 4 (depends on 2)

A topical drug delivery system according to claim 2, wherein the antifungal agent is selected from the list consisting of butenafine, butoconazole, clioquinol, itraconazole, lanoconazole, neticonazole, tioconazole, terconazole, or pharmaceutically acceptable salts or derivatives of any one of the aforementioned antifungal agents.

### Claim 5 (depends on 2)

A topical drug delivery system according to claim 2, wherein the antifungal agent is ciclopirox olamine.

### Claim 6 (depends on 1)

A transdermal drug delivery system according to claim 1, wherein the volatile liquid is ethanol, isopropanol or mixture thereof.

### Claim 7 (depends on 6)

A transdermal drug delivery system according to claim 6 comprising on a weight basis:
a. from about 0.1 to about 10% of the antifungal agent;
b. from about 1 to 10% of the dermal penetration enhancer; and
c. from about 40 to 99.8% ethanol, isopropanol or mixture thereof.

### Claim 8 (depends on 6)

A topical drug delivery system according to claim 6 which comprises on a weight basis:
a. from about 2 to about 8% of the antifungal agent;
b. from about 1 to about 10% of the dermal penetration enhancer; and
c. from about 40 to 98% ethanol, isopropanol, ethyl acetate or mixture thereof; and
d. from about 0.5 to 10% water.

### Claim 9 (depends on 6)

A topical drug delivery system according to claim 6 which comprises on a weight basis:
a. from about 3 to about 8% ciclopirox olamine;
b. from about 1 to about 10% octyl salicylate;
c. from about 40 to 95% ethanol and 40-95% Ethyl Acetate; and
d. from about 1 to 5% water.

### Claim 10 (depends on 6)

A topical drug delivery system according to claim 6 which comprises on a weight basis:
a. from about 3 to about 8% ciclopirox ofamine;
b. from about 1 to about 5% octyl salicylate;
c. from about 45 to 95% ethanol, isopropanol, ethyl acetate or mixture thereof;
d. from about 1 to about 5% water; and
e. from about 0.5 to about 5% of a thickening agent.

### Claim 11 (depends on 1)

A method for administering at least one local acting antifungal agent to an animal which comprises applying an effective amount of the antifungal agent in the form of a drug delivery system according to claim 1.

### Claim 12 (depends on 11)

A method according to claim 11, wherein the antifungal agent is ciclopirox olamine.

### Claim 13 (depends on 12)

A method according to claim 12, wherein the composition is applied to the skin of the human or animal covering a delivery surface area between 10 and 800 cm2.

### Claim 14 (depends on 12)

A method according to claim 12 wherein the composition is applied to the skin of the human or animal covering a delivery surface area between 10 and 400 cm2.

### Claim 15 (depends on 12)

A method according to claim 12, wherein the composition is applied to the skin of the human or animal covering a delivery surface area between 10 and 200 cm2.

### Claim 16 (depends on 15)

A method according to claim 15, wherein the composition is applied using a fixed or variable metered dose applicator.
